InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
64,063.05
(
0.27%
)
Post# of 24977
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mflutie

Send PM Follow Ignore
Followers 81
Posts 2522
Boards Moderated 1
Alias Born 08/05/2002

mflutie

Member Level

Re: None

Monday, 03/06/2006 10:00:05 AM

Monday, March 06, 2006 10:00:05 AM

Post# of 24977
FDA: Asking Panel To Weigh Benefits, Risks Of Tysabri - DJ

09:57 BIIB Biogen Idec: FDA Staff says MANDATORY RISK MANAGEMENT PLAN NEEDED IF BIOGEN, ELAN MS DRUG TYSABRI RETURNS TO MARKET - Reuters (45.45 -0.06) -Update

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up